MedTrace Logo

"Novo C Plus" Vitamin C Containing Dietary Supplement Bioavailability in Healthy Subjects

NCT02606773 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2015-11-17

No results posted yet for this study

Summary

The aim of this study is to evaluate the bioavailability of "Novo C Plus" vitamin C containing dietary supplement compared to licensed vitamin C medications. The novelty of this product is the liposomal formulation.

Conditions

  • Vitamin C Deficiency

Interventions

DRUG

Ascorbic Acid

Ascorbic acid in different ways and doses

Sponsors & Collaborators

  • Novonex Pharma Kft

    collaborator INDUSTRY

  • Semmelweis University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02606773 on ClinicalTrials.gov